The impact of GLP-1 usage is not limited to the food and beverage industries
however, semaglutide (Wegovy, Ozempic, Rybelsus) and liraglutide (Saxenda) are all FDA-approved
Rare risks associated with GLP-1 medications include: Pancreatitis , or inflammation of the pancreas Gallstones and inflammation of the gallbladder leading to biliary colic, sometimes related to rapid weight loss Kidney issues , often linked to dehydration Thyroid tumor warnings , based on animal studies rather than confirmed human cases These risks underscore the importance of medical supervision throughout your treatment
Comparing options: supplements, pills, and prescription medicines Its helpful to keep perspective
Explore Your Weight Loss Options Whether you opt for semaglutide injections, tirzepatide, or choose oral GLP-1 weight loss solutions such as oral Wegovy or Foundayo, Klinic has you covered
I just bought a drug